InvestorsHub Logo
Followers 1
Posts 103
Boards Moderated 0
Alias Born 03/08/2008

Re: None

Wednesday, 08/15/2018 2:26:34 PM

Wednesday, August 15, 2018 2:26:34 PM

Post# of 70
New research paper is out regarding KD025, the ROCK2 inhibitor. "The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6."
Dinarello et al.
It's all lab bench type work that's not going to affect investor appeal but it's more supporting work for the pharmacology of KD025.